Bristol Myers snares another approval from the old Celgene pipeline, nabbing an overlooked OK
Bristol Myers Squibb has gotten another approval from the old Celgene pipeline yesterday, this time for a once low-profile compound.
The FDA green-lighted Onureg, an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
